Article Details

Beyond mAbs: Danaher spies modality manufacturing for genomics and biosimilars in 2025

Retrieved on: 2025-03-06 21:46:16

Tags for this article:

Click the tags to see associated articles and topics

Beyond mAbs: Danaher spies modality manufacturing for genomics and biosimilars in 2025. View article details on hiswai:

Excerpt

“Think monoclonal antibodies in the early 1980s, well, that's just about where we're at here with genomic medicines,” Blair said. “Genomic medicines ...

Article found on: www.bioprocessintl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo